Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$55.63 - $73.24 $188,418 - $248,063
-3,387 Closed
0 $0
Q3 2018

Nov 06, 2018

BUY
$52.05 - $66.51 $176,293 - $225,269
3,387 New
3,387 $223,000
Q2 2018

Jul 23, 2018

SELL
$48.33 - $55.64 $214,295 - $246,707
-4,434 Closed
0 $0
Q1 2018

Apr 24, 2018

BUY
$44.44 - $54.39 $197,046 - $241,165
4,434 New
4,434 $233,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $435M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.